“…Embryonic stem cells (ESCs) have gained considerable interest for their use in developmental toxicity testing by virtue of their fundamental attribute of unlimited expansion and unique potential to differentiate into all somatic cell types (Tandon and Jyoti, 2012). The EST was initially developed as an in vitro model for the screening of embryotoxicity based on the interference of chemicals with the differentiation of mouse embryonic stem cells (mESCs) into beating cardiomyocyte foci in culture (Heuer et al, 1993;Spielmann et al, 1997), and was successfully validated by the European Center for the Validation of Alternative Methods (ECVAM) (Genschow et al, 2004).…”